Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Fampyra launched in Canada

April 12, 2012

Lilly obtains approval in Canada for testosterone replacement therapy

April 12, 2012

Biovest to file marketing application in Canada

April 11, 2012

Health Canada approves grass pollen immunotherapy

March 22, 2012

Health Canada approves diclofenac therapy

March 19, 2012

NDS for insomnia therapy accepted for review by Health Canada

Feb. 23, 2012

Roche obtains Canadian approval for Zelboraf

Feb. 17, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

RedHill Biopharma clear to conduct advanced-stage RHB-102 trial

Feb. 15, 2012

RedHill receives approval from Health Canada to begin RHB-102 trial

Feb. 9, 2012

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....